跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72 条关于
“Panorama”
全部
72
临床试验
52
药物
2
机构
1
资讯
17
前天
Definium Therapeutics to Report Phase 3 Panorama Topline Results for LSD-Based Anxiety Drug DT120
去年
MindMed Advances MM120 for GAD with Phase 3 Trials Underway
前天
Definium's DT120 ODT Hits Primary Endpoint in Second Phase 3 GAD Win, Setting Up First Psychedelic NDA for Anxiety
上个月
Natera Reports Record Signatera Volumes in Q2 2026, Raises Guidance on MRD Market Momentum
去年
Current Treatment Protocols for Ph+ ALL Treatment
去年
MindMed's MM120 Advances in Phase III Trials for GAD and MDD, Stock Surges
去年
DDH Enters Chinese Market with AI Dental Diagnostic Solution 'PANO'
去年
OTX-TKI Shows Promise in Stabilizing Non-Proliferative Diabetic Retinopathy in HELIOS Trial
8个月前
MindMed Rebrands as Definium Therapeutics, Prepares for Three Phase 3 Psychedelic Therapy Readouts in 2026
上个月
APA 2026: Real-World GAD Treatment Gaps and Preclinical Safety Data for 5-HT2A Agonist DT120
第 1 页,共 2 页
上一页
下一页